COMMUNIQUÉS West-GlobeNewswire

Marinus Announces Leadership Transition

26/02/2019 - 15:00

RADNOR, Penn., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]

AXIM® Biotechnologies Announces Successful Microencapsulation of Cannabinoids Into Proprietary Chewing Gum Delivery Mechanism for Clinical Trials

26/02/2019 - 15:00

NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the company has successfully [...]

VistaGen Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock

26/02/2019 - 15:00

SOUTH SAN FRANCISCO, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central [...]

CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2018 Results on March 12, 2019

26/02/2019 - 14:45

LAS VEGAS, Feb. 26, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its fourth quarter and full year 2018 [...]

Nuvectra® to Present at 39th Annual Cowen Healthcare Conference

26/02/2019 - 14:30

PLANO, Texas, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Fred Parks, PhD, Chief Executive Officer, and Walter Berger, Chief [...]

PSIQ to Attend and Display at Champs Trade Show, the Premier Counterculture B2B Expo Since 1999 at the Las Vegas Convention Center February 27th, 2019 Through March 1st, 2019

26/02/2019 - 14:30

SUNRISE, Fla., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ ) through its subsidiary Elite Products International, Inc. (“Elite”) announces it will be attending and displaying at Champs [...]

Sharps Compliance Adds Sharon R. Gabrielson, Chair of Mayo Clinic’s Global Business Solutions, to Board of Directors

26/02/2019 - 14:30

HOUSTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, [...]

SELLAS Life Sciences Announces Review of Strategic Alternatives

26/02/2019 - 14:30

Phase 1/2 basket trial of lead clinical candidate, galinpepimut-S (GPS), plus Keytruda ® (pembrolizumab) ongoing; Phase 3 registrational study for GPS monotherapy in acute myeloid leukemia (AML) planned Discussions on [...]

SpineX Names Scientific Advisory Board to Guide Development of Non-Invasive Medical Devices for Neuromodulation of the Spine

26/02/2019 - 14:15

LOS ANGELES, Feb. 26, 2019 (GLOBE NEWSWIRE) -- SpineX, a developer of non-invasive medical devices to address a broad range of medical conditions through the neuromodulation of the spinal cord to restore function lost [...]

Catalyst Pharmaceuticals Announces Publication of Phase 3 Clinical Trial Data for Firdapse® for the Treatment of Lambert-Eaton Myasthenic Syndrome

26/02/2019 - 14:03

CORAL GABLES, Fla., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]

Blessing Health System expands Allscripts partnership with clinical and financial solutions

26/02/2019 - 14:01

Health system extends and further expands portfolio to provide integrated platform that includes clinical and financial solutions for both acute and ambulatory settings CHICAGO, Feb. 26, 2019 (GLOBE NEWSWIRE) -- [...]

Protech Home Medical Releases Q1 2019 Results; Posts Revenue Growth of 17% and Adjusted EBITDA Growth of 186% Year Over Year

26/02/2019 - 14:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Protech Home [...]

Immutep to Present at Upcoming Industry Conferences

26/02/2019 - 14:00

SYDNEY, Australia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]

BioCorRx Partners with IRISYS for Manufacturing of BICX102 Naltrexone Implant for Treatment of Opioid Use Disorder

26/02/2019 - 14:00

ANAHEIM, CA, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (“Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, announced today [...]

IRIDEX to Report Fourth Quarter and 2018 Financial Results on March 5, 2019

26/02/2019 - 14:00

MOUNTAIN VIEW, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year 2018 after the close of trading [...]

Reminder: Investor Conference Call Today, February 26, 2019; Management to Provide Update on Initiatives & Strategic Plans, Call-in Details

26/02/2019 - 14:00

MIRAMAR, FL, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the following access [...]

MannKind Corporation Fourth Quarter and Year-End 2018 Earnings Call

26/02/2019 - 14:00

Conference Call to Begin Today at 9:00 AM ET 4Q 2018 Total Revenues were $16.0 million; 254% growth vs. 4Q 2017 4Q 2018 Afrezza Net Revenue was $5.7 million; 28% growth vs. 4Q 2017 on a GAAP basis and 86% when adjusted [...]

VBL Presents New Data on the Potential of its Novel VB-600 Platform for Nonalcoholic Steatohepatitis (NASH) and Rheumatoid Arthritis (RA)

26/02/2019 - 14:00

TEL AVIV, Israel, Feb. 26, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), (the “Company”) today announced new data implicating the potential of its VB-600 platform of antibodies targeting MOSPD2 (motile [...]

Avalon GloboCare Announces Filing of Provisional Patent Applications for AVA-101, a Novel Transposon-Based, Multi-Targeted CAR-T Therapy

26/02/2019 - 14:00

AVA-101 designed to enhance efficacy and overcome safety challenges of current CAR-T immune-oncology therapeutics AVA-101 represents a first-in-class transposon-based Chimeric Antigen Receptor (CAR) system targeting [...]